Ad
related to: MRNA Stock
Search results
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 5 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
CureVac (NASDAQ:CVAC) Sees Large Volume Increase
ETF DAILY NEWS· 4 days agoShares of CureVac (NASDAQ:CVAC – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 290,327 shares traded hands during mid-day trading, a decline of 63% from the ...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks via Yahoo Finance· 4 days agoImage Source: Zacks Investment Research Descartes-08 is an autologous anti-B cell maturation antigen...
Navigating the Volatility of Arcturus Therapeutics Holdings Inc’s
NewsHeater· 5 days agoIn the past week, ARCT stock has gone up by 11.60%, with a monthly gain of 15.93% and a quarterly plunge of -13.51%. The volatility ratio for the week is 5.86%, and the volatility ...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks· 7 days agoFree Report) announced that it has entered into a first-in-class artificial intelligence (AI) collaboration with Formation Bio and OpenAI to build AI-powered software to expedite the development ...
Nvidia Rocks, Stocks Lost in the Light, Fed Minutes Takeaways, Solomon's Song
TheStreet.com· 4 days agoMarkets appeared to be less than fully prepared that 'various [Fed] participants' had at least...
8 Health Care Stocks Whale Activity In Today's Session - Abbott Laboratories (NYSE:ABT), AbbVie...
Benzinga· 4 days agoDate Strike Price Total Trade Price Open Interest Volume MRNA CALL SWEEP BEARISH 05/31/24 $170.00 $43.0K 2.0K 3.6K PFE PUT TRADE BEARISH 06/21/24 $29.00 $34.3K 18.0K 2.1K ...
StageZero Life Sciences Announces Update on Failure to File Cease Trade Order
Digital Journal· 4 days agoAristotle® uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform...laboratory in Richmond ...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 3 days agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
FDA grants Cartesian Therapeutics RMAT status for MG therapy By Investing.com
Investing.com· 5 days agoCartesian Therapeutics, a clinical-stage biotechnology company, announced today that the U.S. Food...